,,iv #aai? ,,congress #a/ ,session ,h4 ,,res4 #cfj ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,april #bi1 #bjbe,ms4 ,plaskett 7= h]self1 ,ms4 ,del,bene1 ,ms4 ,br[nley1 ,mr4 ,davis ( ,nor? ,c>ol9a1 ,mrs4 ,*]filus-,mc,cormick1 ,ms4 ,sewell1 ,ms4 ,/ansbury1 ,ms4 ,adams1 ,ms4 ,cl>ke ( ,new ,york1 ,mr4 ,davis ( ,ill9ois1 ,ms4 ,wilson ( ,florida1 & ,mr4 ,johnson ( ,georgia7 submitt$ ! foll[+ resolution2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,,resolution ,express+ support = ! designation ( ! la/ ,tuesday ( ,april ea* ye> z ,,apol#a-,m$iat$ ,kidney ,disease 7,,amkd7 ,aw>5ess ,day4 ,:]eas kidney disease affects an e/imat$ #ce1ejj1jjj ,am]icans1 & m ?an #eej1jjj are on dialysis2 ,:]eas ,black individuals ) kidney disease are m likely to develop kidney failure ?an any o!r racial gr\p2 ,:]eas ! heal? disp>ities 9 kidney failure are unsu/a9able1 ) ,black p mak+ up #ac p]c5t ( ! ,unit$ ,/ates population b acc\nt+ = #cj p]c5t ( ^? ) kidney failure2 ,:]eas kidney failure places enorm\s physical1 emotional1 & f9ancial burd5s on individuals & co/s ! ,m$ic>e ,program ov] #de1jjj1jjj1jjj annually2 ,:]eas !re are g5etic factors t c increase an individual's risk = kidney disease2 ,:]eas "o su* g5etic factor is hav+ v>iants 7mutations7 9 ! apolipoprote9 ,l#a 7,,apol#a7 g5e2 ,:]eas p are m likely to h ,,apol#a g5e v>iants if !y are f ,we/]n or ,c5tral ,africa or h an ance/or :o came f ^! regions2 ,:]eas ^! v>iants c increase susceptibility = ,,apol#a-m$iat$ kidney disease 7,,amkd71 a rapidly progressive =m ( kidney disease t c lead to kidney failure2 ,:]eas1 x is e/imat$ t if a pati5t has v>iants 9 bo? copies ( ! ,,apol#a g5e1 !re is a #a 9 #e *ance !y w g on to develop kidney disease1 & an e/imat$ #ac p]c5t ( ,black ,am]icans h v>iants 9 bo? copies ( ! ,,apol#a g5e2 ,:]eas a p]son ) ,,amkd may n h any symptoms ( kidney disease until _! kidneys are close to fail+2 ,:]eas g5etic te/+ c reveal an individual's risk = ,,amkd1 emp[]+ !m to take ! /eps necess>y to protect _! kidney heal? be=e x is too late2 ,:]eas individuals :o are f\nd to h ,,apol#a g5etic v>iants c r$uce _! risk = kidney failure by meet+ ) _! doctor regul>ly1 eat+ a heal?y diet1 tak+ all m$ications z prescrib$1 ex]cis+ = at lea/ #cj m9utes a day1 & n smok+ or us+ tobacco2 ,:]eas additional aw>5ess & rese>* ( ,,apol#a g5etic mutations are ne$$ to improve und]/&+ ( ! kidney disease disp>ities 9 ?is population2 ,:]eas !re are curr5tly no ,food & ,drug ,adm9i/ration-approv$ treatm5ts available = ,,apol#a-m$iat$ kidney disease1 b ongo+ rese>* & cl9ical trials c\ld provide an opportunity = rese>*]s to develop & te/ safe treatm5ts = ,,apol#a-m$iat$ kidney disease2 & ,:]eas ! ,h\se ( ,repres5tatives c raise public aw>5ess ( ,,apol#a-m$iat$ kidney disease3 ,n[1 !re=e1 be x ,t ! ,h\se ( ,repres5tatives-- 7#a7 expresses support = ! designation ( ,,apol#a-,m$iat$ ,kidney ,disease 7,,amkd7 ,aw>5ess ,day2 7#b7 enc\rages ea* p]son ( ! ,unit$ ,/ates to become bett] in=m$ ab\t & aw>e ( kidney disease & ,,apol#a-m$iat$ kidney disease2 & 7#c7 enc\rages p f or ) ance/ry f ,we/]n & ,c5tral ,africa to consid] g5etic te/+ = ,,apol#a g5e mutations4